News & Perspectives
Discover the latest news, research, expert perspectives and
media from across DXY.
Beyond the Data: The Future of Lung Cancer Innovation | DXY Insight with Professor Caicun Zhou
Introducing DXY Insight: Beyond the Data, an interview series exploring the healthcare and life sciences landscape through expert perspectives. In our first episode, Professor Caicun Zhou, President of the International Association for the Study of Lung Cancer (IASLC), shares his insights on the evolving landscape of lung cancer innovation. From distinguishing meaningful advances from emerging trends to examining China’s role in global oncology research, this conversation explores the developments shaping the future of lung cancer care.
DXY Insight Database at CPIC 2026: AI Drug Discovery Enters the Era of Asset Realization
At the inaugural China Pharmaceutical Innovation Conference (CPIC China 2026), DXY Insight examined how AI drug discovery is moving beyond technological exploration toward clinical validation, commercial partnerships, and the creation of tangible pharmaceutical assets.
Conquering the "Silver Tsunami": Insight Examines the Landscape and Trends of Innovative Drug R&D for Alzheimer's Disease at ICNS 2026
What does the “Silver Tsunami” mean for the future of Alzheimer’s drug development? At ICNS 2026, DXY Insight Database explored key trends shaping the Alzheimer’s drug R&D landscape, from disease-modifying therapies and patient access to earlier diagnosis, multi-target approaches, and market adoption.
DXY Insight Database Redefining Boundaries, Building a Shared Ecosystem: Insight InCity Brings Pharmaceutical BD Leaders Together in Beijing
On August 27, DXY Insight Database hosted the Beijing edition of Insight InCity, bringing together leaders from multinational pharmaceutical companies, innovative biotech and pharma companies, investment institutions, and industry partners to explore the evolving pharma BD landscape.
As AI Enters Medical Decision-Making, Where Will Healthcare Companies Find New Growth Opportunities?
DXY Executive Forum Explores Shifts in Physician Decision-Making and the Future of Healthcare Growth
DXY Founder Stanley Tiantian Li: Turning Physicians’ Needs into a Compass for Drug R&D
At BIOHK 2026, DXY Founder and Chairman Stanley Tiantian Li shared his perspective on how physicians could become true partners in drug R&D, and how clinical needs could help inform new directions for innovation.
DXY Forms Strategic Partnership with Johnson & Johnson Innovative Medicine China to Explore a New Digital Future for Healthcare
DXY and Johnson & Johnson Innovative Medicine China have signed a strategic partnership agreement.
CACA × Cancer Discovery: Advancing Global Oncology Innovation | DXY Expert Roundtable
In this episode of DXY Expert Roundtable, Dr. Robert Kruger and Dr. Fang Wu join us for an in-depth conversation on "CACA × Cancer Discovery: Together for Global Oncology Innovation", exploring how cross-border partnerships can accelerate scientific progress, strengthen clinical practice, and shape the future of cancer care.
